SV40 T/t-common polypeptide enhances the sensitivity of HER2-overexpressing human cancer cells to anticancer drugs cisplatin and doxorubicin. [electronic resource]
Producer: 20121018Description: 48-57 p. digitalISSN:- 1872-7980
- Animals
- Antigens, Polyomavirus Transforming -- genetics
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cisplatin -- pharmacology
- Doxorubicin -- pharmacology
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Mice
- Mice, SCID
- Ovarian Neoplasms -- drug therapy
- Proto-Oncogene Proteins c-bcl-2 -- genetics
- Receptor, ErbB-2 -- genetics
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
- bcl-X Protein -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.